Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Maria Buti & Maria Homs. (2012) Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Expert Review of Gastroenterology & Hepatology 6:4, pages 413-421.
Read now
Read now
Erik De Clercq. (2012) Ten Paths to the Discovery of Antivirally Active Nucleoside and Nucleotide Analogues. Nucleosides, Nucleotides & Nucleic Acids 31:4, pages 339-352.
Read now
Read now
Chang
Hyun Oh, Lian
Jin Liu & Joon
Hee Hong. (2010) Design and Synthesis of Dually Branched 5′-Norcarbocyclic Adenosine Phosphonodiester Analogue as a New Anti-HIV Prodrug. Nucleosides, Nucleotides & Nucleic Acids 29:10, pages 721-733.
Read now
Read now
Hua Li & Joon
Hee Hong. (2010) Synthesis and Anti-HIV Evaluation of New Acyclic Phosphonate Nucleotide Analogues and Their Bis(SATE) Derivatives. Nucleosides, Nucleotides & Nucleic Acids 29:8, pages 581-590.
Read now
Read now
Lian
Jin Liu & Joon
Hee Hong. (2010) Design and Synthesis of Novel Sate Derivatives of Acyclic Isocytosine and 9-Deazaadenine C-Nucleosides. Nucleosides, Nucleotides & Nucleic Acids 29:3, pages 257-266.
Read now
Read now
Aihong Kim & Joon
Hee Hong. (2006) Synthesis and Antiviral Evaluation of Novel 5′-Norcarboacyclic Phosphonic Acid Nucleosides. Nucleosides, Nucleotides & Nucleic Acids 25:8, pages 941-950.
Read now
Read now
Eric Denes & Sylvie Ranger-Rogez. (2005) Main adult herpes virus infections of the CNS. Expert Review of Anti-infective Therapy 3:4, pages 663-678.
Read now
Read now
Erik De Clercq, G. Andrei, J. Balzarini, P. Leyssen, L. Naesens, J. Neyts, C. Pannecouque, R. Snoeck, C. Ying, D. Hocková & A. Holý. (2005) ANTIVIRAL POTENTIAL OF A NEW GENERATION OF ACYCLIC NUCLEOSIDE PHOSPHONATES, THE 6-[2-(PHOSPHONOMETHOXY)ALKOXY]-2,4-DIAMINOPYRIMIDINES. Nucleosides, Nucleotides & Nucleic Acids 24:5-7, pages 331-341.
Read now
Read now
Sylvie Ranger-Rogez & Fran¸ois Denis. (2004) Hepatitis B mother-to-child transmission. Expert Review of Anti-infective Therapy 2:1, pages 133-145.
Read now
Read now
Articles from other publishers (58)
Pavel Kraina, Michal Česnek, Eva Tloušťová, Helena Mertlíková-Kaiserová, Camryn J. Fulton, Emily K. Davidson, Brenton P. Smith, Val J. Watts & Zlatko Janeba. (2023) Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir. Bioorganic & Medicinal Chemistry 95, pages 117508.
Crossref
Crossref
Samantha S. Soldan & Paul M. Lieberman. (2022) Epstein–Barr virus and multiple sclerosis. Nature Reviews Microbiology 21:1, pages 51-64.
Crossref
Crossref
Samantha S Soldan, Troy E Messick & Paul M Lieberman. (2022) Therapeutic approaches to Epstein–Barr virus cancers. Current Opinion in Virology 56, pages 101260.
Crossref
Crossref
Milan Dejmek, Michal Šála, Andrea Brazdova, Lenka Vanekova, Miroslav Smola, Martin Klíma, Petra Břehová, Miloš Buděšínský, Martin Dračínský, Eliška Procházková, Martin Zavřel, Ondřej Šimák, Ondřej Páv, Evzen Boura, Gabriel Birkuš & Radim Nencka. (2022) Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential. Structure 30:8, pages 1146-1156.e11.
Crossref
Crossref
Markéta Pimková Polidarová, Petra Břehová, Martin Maxmilian Kaiser, Miroslav Smola, Martin Dračínský, Joshua Smith, Aleš Marek, Milan Dejmek, Michal Šála, Ondrej Gutten, Lubomír Rulíšek, Barbora Novotná, Andrea Brázdová, Zlatko Janeba, Radim Nencka, Evzen Boura, Ondřej Páv & Gabriel Birkuš. (2021) Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP). Journal of Medicinal Chemistry 64:11, pages 7596-7616.
Crossref
Crossref
Nikoletta Harsági & György Keglevich. (2021) The Hydrolysis of Phosphinates and Phosphonates: A Review. Molecules 26:10, pages 2840.
Crossref
Crossref
Conor O’Halloran. 2021. Greene's Infectious Diseases of the Dog and Cat. Greene's Infectious Diseases of the Dog and Cat
466
469
.
Guang Huan Shen & Joon Hee Hong. (2020) Chemical Synthesis of Acyclic Nucleoside Phosphonate Analogs Linked with Cyclic Systems between the Phosphonate and the Base Moieties. Current Medicinal Chemistry 27:35, pages 5918-5948.
Crossref
Crossref
Martin Maxmilian Kaiser, Pavel Novák, Šárka Rosenbergová, Lenka Poštová‐Slavětínská, Ivan Rosenberg & Zlatko Janeba. (2018)
Acyclic Nucleoside Phosphonates Bearing (
R
)‐ or (
S
)‐9‐[3‐Hydroxy‐2‐(phosphonoethoxy)propyl] (HPEP) Moiety as Monomers for the Synthesis of Modified Oligonucleotides
. European Journal of Organic Chemistry 2018:37, pages 5119-5126.
Crossref
Crossref
N. Sanjib Banerjee, Hsu-Kun Wang, James R. Beadle, Karl Y. Hostetler & Louise T. Chow. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Research 150, pages 164-173.
Crossref
Crossref
Jan Frydrych, Jan Skácel, Markéta Šmídková, Helena Mertlíková-Kaiserová, Martin Dračínský, Ramachandran Gnanasekaran, Martin Lepšík, Monica Soto-Velasquez, Val J. Watts & Zlatko Janeba. (2018) Synthesis of α-Branched Acyclic Nucleoside Phosphonates as Potential Inhibitors of Bacterial Adenylate Cyclases. ChemMedChem 13:2, pages 199-206.
Crossref
Crossref
Martin Maxmilian Kaiser, Ondřej Baszczyňski, Dana Hocková, Lenka Poštová-Slavětínská, Martin Dračínský, Dianne T. Keough, Luke W. Guddat & Zlatko Janeba. (2017) Acyclic Nucleoside Phosphonates Containing 9-Deazahypoxanthine and a Five-Membered Heterocycle as Selective Inhibitors of Plasmodial 6-Oxopurine Phosphoribosyltransferases. ChemMedChem 12:14, pages 1133-1141.
Crossref
Crossref
Jin Wang & Jon D. Rainier. (2014) Reactivity of Vinyl Phosphonate Containing Diazoesters: Formation, Reactivity, and Utility. Organic Letters 17:2, pages 266-269.
Crossref
Crossref
Veronika Šolínová, Martin Maxmilián Kaiser, Miloš Lukáč, Zlatko Janeba & Václav Kašička. (2014) Enantiopurity analysis of new types of acyclic nucleoside phosphonates by capillary electrophoresis with cyclodextrins as chiral selectors. Journal of Separation Science 37:3, pages 295-303.
Crossref
Crossref
Jean-Pierre Uttaro, Sylvie Broussous, Christophe Mathé & Christian Périgaud. (2013) Synthesis of novel 3′-methyl-5′-norcarbocyclic nucleoside phosphonates as potential anti-HIV agents. Tetrahedron 69:9, pages 2131-2136.
Crossref
Crossref
Erik De Clercq. 2013. Antiviral Agents. Antiviral Agents
293
316
.
Daniela Belletti, Giovanni Tosi, Flavio Forni, Maria Cristina Gamberini, Cecilia Baraldi, Maria Angela Vandelli & Barbara Ruozi. (2012) Chemico-physical investigation of tenofovir loaded polymeric nanoparticles. International Journal of Pharmaceutics 436:1-2, pages 753-763.
Crossref
Crossref
Martin Maxmilian Kaiser, Petr Jansa, Martin Dračínský & Zlatko Janeba. (2012) A novel type of acyclic nucleoside phosphonates derived from 2-(phosphonomethoxy)propanoic acid. Tetrahedron 68:21, pages 4003-4012.
Crossref
Crossref
Petr Jansa, Ondřej Baszczyňski, Eliška Procházková, Martin Dračínský & Zlatko Janeba. (2012) Microwave-assisted hydrolysis of phosphonate diesters: an efficient protocol for the preparation of phosphonic acids. Green Chemistry 14:8, pages 2282.
Crossref
Crossref
Charles S. Demmer, Niels Krogsgaard-Larsen & Lennart Bunch. (2011) Review on Modern Advances of Chemical Methods for the Introduction of a Phosphonic Acid Group. Chemical Reviews 111:12, pages 7981-8006.
Crossref
Crossref
Erik De Clercq. 2011. Antiviral Drugs. Antiviral Drugs
85
101
.
Erik De Clercq. (2011) The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond. Biochemical Pharmacology 82:2, pages 99-109.
Crossref
Crossref
Carolina Horta Andrade, Lenis Medeiros de Freitas & Valéria de Oliveira. (2011) Twenty-six years of HIV science: an overview of anti-HIV drugs metabolism. Brazilian Journal of Pharmaceutical Sciences 47:2, pages 209-230.
Crossref
Crossref
Ondřej Baszczyňski, Petr Jansa, Martin Dračínský, Blanka Klepetářová, Antonín Holý, Ivan Votruba, Erik de Clercq, Jan Balzarini & Zlatko Janeba. (2011) Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Bioorganic & Medicinal Chemistry 19:7, pages 2114-2124.
Crossref
Crossref
Jin Wang, Vyacheslav Boyarskikh & Jon D. Rainier. (2011) Vinyl Diazophosphonates as Precursors to Quaternary Substituted Indolines and Cyclopentenes. Organic Letters 13:4, pages 700-702.
Crossref
Crossref
Anna Piperno, Salvatore V. Giofrè, Daniela Iannazzo, Roberto Romeo, Giovanni Romeo, Ugo Chiacchio, Antonio Rescifina & Dorota G. Piotrowska. (2010) Synthesis of C-4′Truncated Phosphonated Carbocyclic 2′-Oxa-3′-azanucleosides as Antiviral Agents. The Journal of Organic Chemistry 75:9, pages 2798-2805.
Crossref
Crossref
Erik De Clercq. (2009) Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective. Journal of Medicinal Chemistry 53:4, pages 1438-1450.
Crossref
Crossref
Youcef Mehellou & Erik De Clercq. (2009) Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?. Journal of Medicinal Chemistry 53:2, pages 521-538.
Crossref
Crossref
Zlatko Janeba, Milena Masojídková & Antonín Holý. (2010) Alternative synthesis of 9-{3-[(diisopropoxyphosphoryl)methoxy]-2-hydroxypropyl}adenine and its free phosphonates substituted at the C-8 position of purine base. Collection of Czechoslovak Chemical Communications 75:3, pages 371-381.
Crossref
Crossref
Erik De Clercq. (2009) Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. International Journal of Antimicrobial Agents 33:4, pages 307-320.
Crossref
Crossref
H. Hillaireau & P. Couvreur. (2009) Nanoencapsulation of antiviral nucleotide analogs. Journal of Drug Delivery Science and Technology 19:6, pages 385-390.
Crossref
Crossref
M.S. Palombo, Y. Singh & P.J. Sinko. (2009) Prodrug and conjugate drug delivery strategies for improving HIV/AIDS therapy. Journal of Drug Delivery Science and Technology 19:1, pages 3-14.
Crossref
Crossref
James D. Cherry & Samantha Johnston. 2009. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Feigin and Cherry's Textbook of Pediatric Infectious Diseases
2101
2108
.
Erik De Clercq. (2008) The discovery of antiviral agents: Ten different compounds, ten different stories. Medicinal Research Reviews 28:6, pages 929-953.
Crossref
Crossref
Tomas Cihlar, William E. DelaneyIVIV & Richard Mackman. 2008. Modified Nucleosides. Modified Nucleosides
601
630
.
Florian van BömmelThomas Berg. (2008) Role of tenofovir in the treatment of chronic HBV infection. Future Virology 3:3, pages 207-220.
Crossref
Crossref
Jeremiah W. Hanes, Yali Zhu, Deborah S. Parris & Kenneth A. Johnson. (2007) Enzymatic Therapeutic Index of Acyclovir. Journal of Biological Chemistry 282:34, pages 25159-25167.
Crossref
Crossref
Ana L. Mora, Edilson Torres-González, Mauricio Rojas, Jianguo Xu, Jeffrey Ritzenthaler, Samuel H. Speck, Jesse Roman, Kenneth Brigham & Arlene Stecenko. (2007) Control of Virus Reactivation Arrests Pulmonary Herpesvirus-induced Fibrosis in IFN-γ Receptor–deficient Mice. American Journal of Respiratory and Critical Care Medicine 175:11, pages 1139-1150.
Crossref
Crossref
E. De Clercq. (2007) Acyclic nucleoside phosphonates: Past, present and future. Biochemical Pharmacology 73:7, pages 911-922.
Crossref
Crossref
Martin Welin, Liya Wang, Staffan Eriksson & Hans Eklund. (2007) Structure-function Analysis of a Bacterial Deoxyadenosine Kinase Reveals the Basis for Substrate Specificity. Journal of Molecular Biology 366:5, pages 1615-1623.
Crossref
Crossref
Erik De Clercq. 2007.
1
58
.
E. De Clercq. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
253
293
.
Joachim J. Bugert. 2007. Poxviruses. Poxviruses
89
112
.
Erik De Clercq. (2006) The role of tenofovir in the prevention of HIV infections. AIDS 20:15, pages 1990-1991.
Crossref
Crossref
Tomas Cihlar. (2006) Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond. Current Opinion in HIV and AIDS 1:5, pages 373-379.
Crossref
Crossref
Erik De Clercq. (2006) Interferon and Its Inducers—A Never-Ending Story: “Old” and “New” Data in a New Perspective. The Journal of Infectious Diseases 194:Supplement_1, pages S19-S26.
Crossref
Crossref
Erik De Clercq. (2006) A guided tour through the antiviral drug field. Future Virology 1:1, pages 19-35.
Crossref
Crossref
Erik De Clercq & Antonín Holý. (2005) Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nature Reviews Drug Discovery 4:11, pages 928-940.
Crossref
Crossref
Aihong Kim & Joon Hee Hong. (2005) Synthesis and Anti‐HCMV Activity of Novel 5′‐Norcarboacyclic Nucleosides. Archiv der Pharmazie 338:11, pages 522-527.
Crossref
Crossref
Hui-chang Bi, Guo-ping Zhong, Shufeng Zhou, Xiao Chen & Min Huang. (2005) Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study. Rapid Communications in Mass Spectrometry 19:20, pages 2911-2917.
Crossref
Crossref
Erik De Clercq. (2005) Recent highlights in the development of new antiviral drugs. Current Opinion in Microbiology 8:5, pages 552-560.
Crossref
Crossref
Erik De Clercq. (2005) Antiviral drug discovery and development: Where chemistry meets with biomedicine. Antiviral Research 67:2, pages 56-75.
Crossref
Crossref
Erik De Clercq. (2005) New Approaches toward Anti-HIV Chemotherapy. Journal of Medicinal Chemistry 48:5, pages 1297-1313.
Crossref
Crossref
Wataru SUGIURA. (2005) Progress in antiretroviral drugs. Uirusu 55:1, pages 85-94.
Crossref
Crossref
Erik De Clercq. (2004) Antivirals and antiviral strategies. Nature Reviews Microbiology 2:9, pages 704-720.
Crossref
Crossref
Erik De Clercq & Johan Neyts. (2004) Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections. Reviews in Medical Virology 14:5, pages 289-300.
Crossref
Crossref
Erik De Clercq. (2004) Antiviral drugs in current clinical use. Journal of Clinical Virology 30:2, pages 115-133.
Crossref
Crossref
Richard L. Mackman & Tomas Cihlar. 2004.
305
321
.